---
audienceLevel: patient
cancerTypes:
- myeloma
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- cancer-type
title: Plasma Cell Neoplasms (Including Multiple Myeloma)—Health Professional Version
  - NCI
url: https://www.cancer.gov/types/myeloma/hp
version: v1
---

# Plasma Cell Neoplasms (Including Multiple Myeloma)—Health Professional Version - NCI

# Plasma Cell Neoplasms (Including Multiple Myeloma)—Health Professional Version

[Go to Patient Version](/types/myeloma)

## Treatment

#### PDQ Treatment Information for Health Professionals

- [Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment](/types/myeloma/hp/myeloma-treatment-pdq)

##### More information

- [Drugs Approved for Multiple Myeloma and Other Plasma Cell Neoplasms](/about-cancer/treatment/drugs/multiple-myeloma)
- [Clinical Trials to Treat Multiple Myeloma/Plasma Cell Myeloma](https://www.cancer.gov/about-cancer/treatment/clinical-trials/disease/multiple-myeloma-plasma-cell-myeloma/treatment)

## Causes & Prevention

NCI does not have PDQ evidence-based information about prevention of plasma cell neoplasms (including multiple myeloma).

##### More information

- [Cancer Prevention Overview (PDQ®)](/about-cancer/causes-prevention/hp-prevention-overview-pdq)

## Screening

NCI does not have PDQ evidence-based information about screening for plasma cell neoplasms (including multiple myeloma).

##### More information

- [Cancer Screening Overview (PDQ®)](/about-cancer/screening/hp-screening-overview-pdq)

## Research

[FDA Approvals Expand Initial Treatment Options for Multiple Myeloma](/news-events/cancer-currents-blog/2025/fda-daratumumab-isatuximab-newly-diagnosed-myeloma)

[Trial Results Support Adding Daratumumab to Initial Treatment for Multiple Myeloma](/news-events/cancer-currents-blog/2024/multiple-myeloma-darzalex-plus-vrd)

[Motixafortide May Improve Stem Cell Transplants for People with Multiple Myeloma](/news-events/cancer-currents-blog/2023/motixafortide-multiple-myeloma-stem-cell-transplant)

[Teclistamab Shows Promise for People with Heavily Pretreated Multiple Myeloma](/news-events/cancer-currents-blog/2022/tecvayli-multiple-myeloma)

[View more research](/types/myeloma/research/articles)

## Statistics

[![Pictograph showing figures representing statistics, with green figures indicating one group and gray figures indicating another group, arranged in three rows for comparison purposes.](/sites/g/files/xnrzdm211/files/styles/cgov_panoramic/public/cgov_image/panoramic/900/600/files/survival-panoramic.jpg?itok=BrPp_4T_)](http://seer.cancer.gov/statfacts/html/mulmy.html)

[Plasma cell neoplasms (including multiple myeloma) statistics based on data from large groups of patients to be used as a general guide.](http://seer.cancer.gov/statfacts/html/mulmy.html)

## Supportive & Palliative Care

We offer evidence-based supportive and palliative care information
for health professionals on the assessment and management of cancer-related symptoms and conditions.

[Cancer Pain](/about-cancer/treatment/side-effects/pain/pain-hp-pdq)
[Nausea and Vomiting](/about-cancer/treatment/side-effects/nausea/nausea-hp-pdq/)
[Nutrition in Cancer Care](/about-cancer/treatment/side-effects/appetite-loss/nutrition-hp-pdq)
[Transition to End-of-Life Care](/about-cancer/advanced-cancer/planning/end-of-life-hp-pdq)
[Last Days of Life](/about-cancer/advanced-cancer/caregivers/planning/last-days-hp-pdq)
[View all Supportive and Palliative Care Summaries](/publications/pdq/information-summaries/supportive-care)
